COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
Researchers are gaining insights into how external factors like air pollutants, diet and medications, and even microbes in the gut interact with regulatory T cells, for better or for worse.
Regulatory T cells help your immune system distinguish between ‘self’ and ‘nonself’ – and can open doors to better treatments for cancer, autoimmune disease and transplant rejection.
As it does with other pathogens, your immune system sees drugs as foreign invaders to be expelled from your body. But exploiting this process could reduce the side effects of chemotherapy.
Some studies indicate children with pets may be less likely to have allergies. But the evidence can be tricky to interpret.
Not only do mitochondria serve as the engine of the cell – they also act as watchtowers for the immune system.
The virus that causes eastern equine encephalitis, or EEE, has evolved to infect mosquitoes. To be able to spread between people, however, it faces extra challenges.
Researchers developed a new mouse model that replicates long COVID-19 more accurately than current models. Their findings could lead to new treatments.
Is it time to cut the men in your life some slack this winter? Here’s what the evidence says.